Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zalutumumab PK in SCCHN
NCT01054625Phase 2Completed
- Sponsor
- Genmab
- Start
- Mar 2010
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of zalutumumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Genmab. Started Mar 2010; status: completed.
02
Drugs
zalutumumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01054625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01054625.